203 related articles for article (PubMed ID: 22709620)
1. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.
Hernando V; Perez-Cachafeiro S; Lewden C; Gonzalez J; Segura F; Oteo JA; Rubio R; Dalmau D; Moreno S; Amo JD;
J Hepatol; 2012 Oct; 57(4):743-51. PubMed ID: 22709620
[TBL] [Abstract][Full Text] [Related]
2. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
[TBL] [Abstract][Full Text] [Related]
3. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
4. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
[TBL] [Abstract][Full Text] [Related]
5. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
Gibson A; Randall D; Degenhardt L
Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
[TBL] [Abstract][Full Text] [Related]
6. Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy.
Berenguer J; Alejos B; Hernando V; Viciana P; Salavert M; Santos I; Gómez-Sirvent JL; Vidal F; Portilla J; Del Amo J;
AIDS; 2012 Nov; 26(17):2241-6. PubMed ID: 22781223
[TBL] [Abstract][Full Text] [Related]
7. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
[TBL] [Abstract][Full Text] [Related]
8. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
Duberg AS; Törner A; Davidsdóttir L; Aleman S; Blaxhult A; Svensson A; Hultcrantz R; Bäck E; Ekdahl K
J Viral Hepat; 2008 Jul; 15(7):538-50. PubMed ID: 18397223
[TBL] [Abstract][Full Text] [Related]
9. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.
van Santen DK; van der Helm JJ; Grady BP; de Vos AS; Kretzschmar ME; Stolte IG; Prins M
AIDS; 2014 Nov; 28(17):2589-99. PubMed ID: 25211439
[TBL] [Abstract][Full Text] [Related]
10. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
Kielland KB; Skaug K; Amundsen EJ; Dalgard O
J Hepatol; 2013 Jan; 58(1):31-7. PubMed ID: 22960427
[TBL] [Abstract][Full Text] [Related]
11. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
[TBL] [Abstract][Full Text] [Related]
12. [Mortality and causes of death among intravenous drug addicts in Oslo].
Eskild A; Magnus P; Samuelsen SO; Sohlberg C; Kittelsen P
Tidsskr Nor Laegeforen; 1993 Apr; 113(11):1331-3. PubMed ID: 8337619
[TBL] [Abstract][Full Text] [Related]
13. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
[TBL] [Abstract][Full Text] [Related]
14. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
15. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
16. "Immune activation, aging and gender" and progression of liver disease.
Nasta P
Acta Biomed; 2011 Aug; 82(2):115-23. PubMed ID: 22480066
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS.
Vivithanaporn P; Nelles K; DeBlock L; Newman SC; Gill MJ; Power C
J Neurol Sci; 2012 Jan; 312(1-2):45-51. PubMed ID: 21925684
[TBL] [Abstract][Full Text] [Related]
18. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
[TBL] [Abstract][Full Text] [Related]
20. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
